- Home
- KULR vs SLDB Comparison
KULR vs SLDB Comparison
Compare KULR & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KULR
- SLDB
- Stock Information
- Founded
- KULR 2013
- SLDB 2013
- Country
- KULR United States
- SLDB United States
- Employees
- KULR N/A
- SLDB N/A
- Industry
- KULR Electrical Products
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KULR Technology
- SLDB Health Care
- Exchange
- KULR Nasdaq
- SLDB Nasdaq
- Market Cap
- KULR 241.0M
- SLDB 234.8M
- IPO Year
- KULR N/A
- SLDB 2018
- Fundamental
- Price
- KULR $6.44
- SLDB $7.00
- Analyst Decision
- KULR Strong Buy
- SLDB Strong Buy
- Analyst Count
- KULR 2
- SLDB 10
- Target Price
- KULR $40.00
- SLDB $15.10
- AVG Volume (30 Days)
- KULR 3.5M
- SLDB 1.7M
- Earning Date
- KULR 08-11-2025
- SLDB 08-12-2025
- Dividend Yield
- KULR N/A
- SLDB N/A
- EPS Growth
- KULR N/A
- SLDB N/A
- EPS
- KULR N/A
- SLDB N/A
- Revenue
- KULR $11,436,983.00
- SLDB N/A
- Revenue This Year
- KULR $87.77
- SLDB N/A
- Revenue Next Year
- KULR $102.93
- SLDB N/A
- P/E Ratio
- KULR N/A
- SLDB N/A
- Revenue Growth
- KULR 16.47
- SLDB N/A
- 52 Week Low
- KULR $1.60
- SLDB $2.41
- 52 Week High
- KULR $43.92
- SLDB $10.37
- Technical
- Relative Strength Index (RSI)
- KULR 44.50
- SLDB 75.71
- Support Level
- KULR $6.46
- SLDB $5.74
- Resistance Level
- KULR $6.98
- SLDB $7.12
- Average True Range (ATR)
- KULR 0.59
- SLDB 0.48
- MACD
- KULR 0.13
- SLDB 0.11
- Stochastic Oscillator
- KULR 20.63
- SLDB 94.50
About KULR KULR Technology Group Inc.
KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.